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Abstract
A major problem for the effective diagnosis and management of prion diseases is the lack of rapid high-throughput assays
to measure low levels of prions. Such measurements have typically required prolonged bioassays in animals. Highly
sensitive, but generally non-quantitative, prion detection methods have been developed based on prions’ ability to seed
the conversion of normally soluble protease-sensitive forms of prion protein to protease-resistant and/or amyloid fibrillar
forms. Here we describe an approach for estimating the relative amount of prions using a new prion seeding assay called
real-time quaking induced conversion assay (RT-QuIC). The underlying reaction blends aspects of the previously described
quaking-induced conversion (QuIC) and amyloid seeding assay (ASA) methods and involves prion-seeded conversion of the
alpha helix-rich form of bacterially expressed recombinant PrP
C to a beta sheet-rich amyloid fibrillar form. The RT-QuIC is as
sensitive as the animal bioassay, but can be accomplished in 2 days or less. Analogous to end-point dilution animal
bioassays, this approach involves testing of serial dilutions of samples and statistically estimating the seeding dose (SD)
giving positive responses in 50% of replicate reactions (SD50). Brain tissue from 263K scrapie-affected hamsters gave SD50
values of 10
11-10
12/g, making the RT-QuIC similar in sensitivity to end-point dilution bioassays. Analysis of bioassay-positive
nasal lavages from hamsters affected with transmissible mink encephalopathy gave SD50 values of 10
3.5–10
5.7/ml, showing
that nasal cavities release substantial prion infectivity that can be rapidly detected. Cerebral spinal fluid from 263K scrapie-
affected hamsters contained prion SD50 values of 10
2.0–10
2.9/ml. RT-QuIC assay also discriminated deer chronic wasting
disease and sheep scrapie brain samples from normal control samples. In principle, end-point dilution quantitation can be
applied to many types of prion and amyloid seeding assays. End point dilution RT-QuIC provides a sensitive, rapid,
quantitative, and high throughput assay of prion seeding activity.
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Introduction
The transmissible spongiform encephalopathies (TSEs) or
prion diseases are fatal neurodegenerative disorders that include
human Creutzfeldt-Jakob disease (CJD), bovine spongiform
encephalopathy (BSE), sheep scrapie, cervid chronic wasting
disease (CWD), and transmissible mink encephalopathy (TME).
The infectious agent, or prion, of the TSEs appears to be
composed primarily of an abnormal, misfolded, oligomeric form
of prion protein (PrP
Sc). PrP
Sc is formed post-translationally from
the normal cellular prion protein (PrP
C)[ 1 , 2 ] .P r P
Sc,w h i c hi n
purified form can resemble amyloid fibrils, induces the polymer-
ization and conformational conversion of PrP
C to infectious PrP
Sc
[3–5] or to PrP
Sc-like partially protease-resistant forms (PrP
res)i n
a variety of in vitro reactions [4,6–8]. These studies demonstrate
that PrP
Sc can self-propagate, and although the mechanism is
not fully understood, it appears to be a seeded or templated
polymerization [9–11].
The ability to detect prions rapidly and sensitively would be an
important asset in managing TSEs. Early prion detection in
individuals is critical to the prevention of spread and the initiation
of potential treatments. Prions can be found in a wide variety of
tissues and accessible bodily fluids from infected mammalian hosts,
including blood [12–17], breast milk [18,19], saliva [15,20], urine
[21,22], feces [23], and nasal fluids [24]. In most cases, our ability
to rapidly measure prion infectivity in these fluids is limited by the
low amount of infectious agent. Knowledge of the prion titers in
these fluids or tissues and their products is key for prion diagnosis
and in assessing the public health exposure risks to those materials.
The most direct and reliable assay for the detection of TSE
infectivity is animal bioassay. Quantitation of infectivity can be
achieved by end-point [25] or limiting dilution bioassays [26]. For
some combinations of prion agent and host species, strong
correlations between infectivity titer and disease incubation period
have been established in laboratory rodents, allowing the use of
incubation period to measure infectivity levels [27,28]. The
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time-consuming and expensive. For certain murine-adapted
scrapie strains, the cell culture based standard scrapie cell assay
(SSCA) can also be used to measure infectivity levels by end-point
and limiting dilution methods [29]. The SSCA offers several
advantages over animal bioassays but it still requires weeks to
perform and has been limited to a few mouse-adapted scrapie
strains. The limitations of the animal bioassay and SSCA have
provided strong motivation to develop more practical assays for
prion quantitation.
Several extremely sensitive in vitro methods for prion detection
have been reported. Using the protein misfolding cyclic amplifi-
cation (PMCA) reaction in multi-round sonicated reactions with
brain-derived PrP
C as a substrate, as little as 1 ag of PrP
sc can be
detected [30]. The speed and practicality of PMCA assays have
been improved by the use of bacterially-expressed recombinant
PrP
C (rPrP
c) [31] and by substituting shaking for the sonication
step as described for quaking-induced conversion (QuIC) reactions
[32,33]. The QuIC assay can detect sub-femtogram amounts of
PrP
Sc (less than one lethal intracerebral dose) in hamster brain
homogenates (BH) within a single day. The effectiveness of the
QuIC assay for prion detection was demonstrated by its ability to
discriminate normal from prion-infected hamsters using 2 ml
samples of cerebral spinal fluid (CSF) [32,33] or nasal lavage [24].
The latest adaptations of QuIC reactions have led to the sensitive
detection of variant CJD (vCJD) in human tissue and scrapie in
sheep tissue [33]. The readout for QuIC and PMCA assays is the
detection of specific protease-resistant prion-seeded products by
immunoblotting, which is difficult to adapt to automated high-
throughput formats. An alternative, and potentially higher-
throughput approach was used for the amyloid seeding assay
(ASA) in which the fluorescent dye thioflavin T (ThT) was used to
detect prion seeding of rPrP
C polymerization [34]. The ASA can
also detect protease sensitive disease-causing prions and has a 98%
correlation with neuropathological signs of prion disease [35].
However, a potentially confounding aspect of ASA is the frequent
spontaneous formation of rPrP fibrils (without seeding by prions)
soon after prion-seeded reactions [34].
Until very recently, a major limitation of the PMCA, QuIC and
ASA methods was the lack of prion quantitation. While the present
paper was under review, Chen and colleagues reported a method
called quantitative PMCA (qPMCA) in which PrP
Sc content is
estimated by the number of PMCA rounds necessary for a positive
response [36]. Here we describe a distinct end-point dilution
approach to relative prion quantitation with in vitro prion seeding
assays which is analogous to the end-point dilution titrations
classically used in animal bioassays. At the same time, we describe a
new prion-seeded rPrP
c polymerization assay, real-time (RT)-
QuIC, which combines several aspects of the QuIC assay
(intermittent shaking, rPrP
C preparation, sample preparation, and
a lack of chaotropic salts) with a fluorescent ThT readout, but with
greatly reduced spontaneous rPrP fibril formation. Some elements
of this new assay were first developed using human rPrP
c and
designated ‘‘real-time QUIC’’ by analogy with real-time PCR (R.
Atarashi, K. Satoh, K. Sano, T. Fuse, N. Yamaguchi, D. Ishibashi,
T. Matsubara, T. Nakagaki, H. Yamanaka, S. Shirabe, M.
Yamada, H. Mizusawa, T. Kitamoto, G. Klug, A. McGlade, S. J.
Collins, and N. Nishida, manuscript submitted). The latter
manuscript describes the non-quantitative application of RT-QuIC
to the detection of prions in CSF of human patients with multiple
types of sporadic CJD. In the present study, we have applied RT-
QuIC to prions of sheep, deer and hamsters, and measured prion
seeding activity in the nasal fluids and CSF of prion-infected
hamsters. In conjunction with the end-point dilution analysis that
we describe here, the RT-QuIC assay can rapidly determine
relative prion concentrations with a sensitivity that rivals that of
animal bioassays, but with greatly reduced time and cost.
Materials and Methods
Recombinant prion protein purification
DNA Sequences coding for hamster (residues 90–231 and 23–
231; accession K02234), deer (residues 24–234; accession
AF156185) and sheep (residues 25–234; accession AJ567988)
rPrP
c residues were amplified and ligated into the pET41 vector
(EMD Biosciences) and sequences were verified. After transform-
ing the plasmids into E. coli Rosetta cells (EMD Biosciences), we
expressed the rPrP
c using the Overnight Express Autoinduction
system (EMD Biosciences). Cell pellets from 0.25 L cultures were
then put through two liquid nitrogen freeze thaw cycles and
further lysed with BugBuster master mix (EMD Biosciences) to
isolate the inclusion bodies. Next, the inclusion bodies were
washed twice with 0.16BugBuster, pelleted by centrifugation, and
frozen at 220uC for later use. Then they were denatured in 8 M
guanidine-HCl at pH=8.5 on a rotator for 50 min at room
temperature. Following a 16,0006g spin for 5 min, the denatured
protein was then bound to Ni-NTA Superflow resin (Qiagen) that
had been equilibrated in denaturing buffer [100 mM sodium
phosphate (pH 8.0), 10 mM tris, 6 M guanidine-HCl]. The resin
was loaded into a column and, using an AKTA Explorer system
(GE Healthcare), the denatured protein was refolded on the
column using a linear gradient to refolding buffer [100 mM
sodium phosphate (pH 8.0) and 10 mM tris] over 4.5 h at a flow
rate of 0.75 mL/min. Next the protein was eluted with a linear
gradient to elution buffer [100 mM sodium phosphate (pH 5.8),
10 mM tris, and 500 mM imidazole] at 2 mL/min over 45 min.
The protein fractions were diluted 5–10-fold into dialysis buffer
[10 mM phosphate (pH 5.8)], filtered with a 0.2 mm syringe filter,
and dialyzed. The concentration of rPrP
c was determined by
measuring absorbance at 280 nm and purity was $99%, as
estimated by SDS-PAGE (see Results), immunoblotting (data not
shown), and mass spectrometry (mass=16,238 amu; data not
Author Summary
Prion diseases are deadly infectious neurodegenerative
disorders of mammals which involve the misfolding of
host prion protein. To better manage these diseases, we
need to be able to detect and quantify the infectious
particles, or prions, in biological samples. However, current
tests lack the sensitivity, speed and/or quantitative
capabilities required for many important applications in
medicine, agriculture, wildlife biology and research. To
address this problem, we have developed a new prion
assay that is highly sensitive, rapid, and quantitative. This
assay takes advantage of the ability of miniscule amounts
of infectious prions to seed the misfolding of large
excesses of normal prion protein in test tube reactions.
Quantitation is achieved by testing a range of sample
dilutions and determining loss of seeding activity, i.e. the
end-point dilution. Similar analyses have long been used
to quantify prions by inoculation into animals; however,
such bioassays take months or years to perform and are
both animal-intensive and expensive. Our new method
provides a more practical means of detecting and
quantifying prions. So far, we have applied this assay to
prions from sheep, deer, and hamsters, and have found
surprisingly high levels of prions in the nasal and cerebral
spinal fluids of infected hamsters.
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c preparations were aliquotted and stored at
0.2–0.4 mg/mL and 280uC.
Tissue homogenate preparation
Hamster, deer and sheep 10% (w/v) BH’s were prepared as
previously described [30] and stored at 280uC. For dilution
analysis, BH’s were serially diluted (5–10-fold) in 0.1% SDS in
phosphate buffered saline (PBS) containing 130 mM NaCl with
N2 media supplement (Gibco) as a source of carrier protein [31–
33]. Two microliter aliquots of the BH dilutions were used to seed
RT-QuIC reactions.
Normal hamster muscle and spleen tissue were isolated, snap
frozen in liquid nitrogen, and stored at 280uC until later use. Five
3 mmglassbeadswereplacedina2 mLscrewcaptube.Next,0.1 g
tissue was combined with 900 mL ice cold PBS and homogenized in
two 30 s sessions with the mini beadbeater (Biospec Products) set to
the homogenize setting. Further homogenization was accomplished
with a mini 1.5 mL tube plastic mortar and pestle. Following a
5 min 10006g clarification spin, the supernatant was collected,
aliquotted and frozen for later use.
Nasal lavage sample preparation
Weanling, Syrian golden hamsters (Simonsen Laboratories,
Gilroy, CA) were i.c.-inoculated as described previously [24].
Collection of nasal lavages was also performed as previously
described [24] and samples were stored at 280uC until use. After
thawing, 4 mL nasal lavage was combined with 4 mL 0.05% SDS
in PBS with N2 and serially diluted 5–10-fold for RT-QuIC
dilution analysis. The amount of HY TME infectivity was
measured in nasal lavages using a hamster bioassay. Fifty
microliters of each nasal lavage in PBS was i.c.-inoculated into
six Syrian hamsters and the time to onset of clinical symptoms was
recorded. HY TME titer was inversely proportional to the
incubation period and was estimated using the incubation interval
assay as previously reported [24].
Cerebral spinal fluid sample preparation
CSF samples from hamsters i.c.-inoculated with 263K were
collected at the clinical stage of disease as previously described
(Atarashi 2007). After thawing, 2 mL CSF was combined with
2 mL 0.1% SDS/PBS/N2 and serially diluted 5-fold for RT-QuIC
dilution analysis.
RT-QuIC method
RT-QuIC buffer (RTQB) composition was as follows: 10 mM
phosphate buffer (pH 7.4), 130–500 mM NaCl, 0.1 mg/mL
rPrP
C,1 0mM ThT, and 10 mM ethylenediaminetetraacetic acid
tetrasodium salt (EDTA). RTQB (92,96, or 98 ml, depending upon
the volume of the seed samples) was loaded into wells of a black
96-well plate with a clear bottom (Nunc) and seeded with a 2–8 ml
seed sample for final reaction volume of 100 mL. All reactions
contained equivalent final concentrations of SDS (0.002%).
The plates were sealed with a plate sealer film (Nalgene Nunc
International, catalog #265301) and then incubated in BMG
Polarstar or Fluostar plate reader at 42uC for 20–68 h with cycles
of 1 min shake (700 rpm double orbital) and 1 min rest
throughout the incubation. ThT fluorescence measurements
(450+/2 10 nm excitation and 480+/2 10 nm emission; bottom
read, 20 flashes per well, manual gain of 2000, and 20 ms
integration time) were taken every 15 min. For SDS-PAGE
analysis, the RT-QuIC products were incubated with or without
3.5 mg/mL proteinase K (PK) in the presence of 0.27% N-
lauroylsarcosine sodium salt for 1 h at 37uC followed by the
addition of sample buffer, a 1 min high speed vortex, and a
10 min boil prior to analysis by SDS-PAGE and Deep Purple
protein staining (GE Amersham).
RT-QuIC analyses
Hamster 263K-inoculated BHs and CSFs and HY TME BHs
were analyzed in the RT-QuIC with 8 replicates for each dilution,
while nasal lavage samples were tested with 4 replicates. This study
used four stocks of 10% BH from hamsters clinically affected with
263K scrapie (2 stocks from 2007 [37,38], 1 stock from 1983, and
1 from 1998) that had been previously analyzed by hamster
bioassay. Each stock was serially diluted as stated above and used
to seed RT-QuIC reactions. Three dilution analysis experiments
were done on separate days for each stock. In each experiment,
eight replicates were used for each BH dilution except for the first
experiment for each stock in which normal BH-seeded samples
were run in replicates of four. Also, at least two different batches of
rPrP
c and RTQB were used for each 263K stock analysis.
Within an individual experiment, the average variance in
baseline ThT fluorescence from all 12 negative control experi-
ments (320 individual wells) seeded with normal BH (NBH) was
5.4%. The plate reader measures ThT fluorescence in relative
fluorescent units (rfu) with saturation occurring at ,260,000. After
a lag phase, virtually all prion seeded reactions rise to saturating
fluorescence values (see next paragraph). We chose to run our BH
dilution analysis reactions for 45 h because little sensitivity was
gained beyond this time span. Nasal lavage samples were analyzed
at 20 h to achieve optimal discrimination at the dilutions chosen.
A Spearman-Ka ¨rber analysis analogous to a bioassay’s lethal
dose 50% (LD50) [39] was used to estimate a seeding dose or
dilution at which 50% of the wells became ThT positive (SD50).
For this purpose, each well was considered analogous to an
inoculated animal in a bioassay. In rare cases, the fluorescence in
individual wells rose above baseline but did not reach saturation at
,260,000 rfu within the duration of the reaction. To incorporate
these intermediate reactions into Spearman-Ka ¨rber determina-
tions of a SD50 value, we arbitrarily designated positive reactions
as those with fluorescent readings of .200% of the average
negative control fluorescence, although in our experience, these
borderline cases were so rare as to scarcely influence the final SD50
values. For Spearman-Ka ¨rber analysis a dilution series with at
least one dilution giving 100% ThT positivity and at least one
dilution giving 0% ThT positivity was chosen. The 50% end-point
was calculated using the following formula: xp=1+1/2d - dgp
(xp=1: highest log dilution giving all positive responses; d= log
dilution factor; p= proportion positive at a given dose; gp= the
sum of values of p for xp=1 and all higher dilutions).
Spectroscopy
For circular dichroism (CD) spectroscopy, hamster rPrP
C 90-
231 was at 0.3 mg/mL in 10 mM sodium phosphate buffer
(pH 5.8). CD measurements were performed at 20uC on an OLIS
DSM 17 CD spectrophotometer (On-Line Instrument Systems,
Inc.) with the following parameters: fixed bandwidth =2 nm and
constant integration time of 5 seconds. A quartz cylindrical cell
with a 1 mm pathlength was used. Data were collected from 262–
185 nm with 1 datum/0.55 nm with constant nitrogen gas purge.
The resulting spectra were acquired in a single scan, followed by
subtraction of the sodium phosphate buffer baseline, and
incorporation of a 13-point Savitzky-Golay smoothing filter.
Fourier transform infrared spectroscopy (FTIR) was performed
using a Perkin-Elmer Spectrum 100 instrument equipped with a
diamond attenuated total reflectance sample unit and an MCT
detector. For analysis of rPrP
C 90–231, 2.5 ml of a freshly thawed
Rapid Prion Quantitation
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QuIC was applied to the diamond. 263K-seeded rPrP
res generated in
a ThT-free RT-QuIC reaction and 263K PrP
Sc purified from
hamster brain tissue [40] were pelleted, washed in water, and applied
to the diamond as thick slurries containing 10–40 mg protein. After
application to the diamond, the samples were dried under a stream of
nitrogen while collecting serial background-subtracted spectra, each
comprised of 64 accumulations (4 cm
21 resolution; 1 cm/sec OPD
velocity; strong apodization). The rapid loss of the initially dominant
liquid water signal (,1640 cm
21) was followed until the protein
amide I and II bands predominated and no further changes due to
the evaporation of water were observed (within a few minutes).
Ethics statement
Rocky Mountain Laboratories is an Association for Assessment
of Laboratory Animal Care (AALAC)-accredited facility, and all
animal procedures were carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the institution’s Animal Use and Care
Committee and the National Institutes of Health (Protocol
Number: 2003-11.4). All surgery was performed under isoflurane
anesthesia, and all efforts were made to minimize suffering.
Results
A real-time QuIC assay for prions
The RT-QuIC assay incorporates rPrP
c as a substrate,
intermittent shaking of the reactions in 96-well plates, detergent-
and chaotrope-free reaction conditions, and ThT-based fluores-
cence detection of prion-seeded rPrP
c amyloid fibrils. As described
for the ASA [34] and other ThT-based seeded amyloid fibrilliza-
tions assays [41], the advantage of using ThT detection is that it can
be included in the reaction mixture. In the presence of amyloid
fibrils, ThT undergoes an enhancement of fluorescence yield as well
as a spectral shift in excitation/emission maxima that can be
measured frequently over the RT-QuIC time course. In Figure 1,
RT-QuIC reactions containing hamster rPrP
c 90–231 (comprised
of residues 90–231) showed increased ThT fluorescence after lag
phases of 2–4 h when seeded with a 10
23 dilution of BH from
hamsters clinically affected with 263K scrapie. Each data point on
the graph represents the averagefluorescence from 8 replicate wells.
The duration of the lag phase increased with higher dilutions of
263K brain. At 10
29 and 10
210 dilutions only 4 of 8 and 1 of 8
replicate wells, respectively, showed positive reactions. The rapid
negative-to-positive conversion of individual wells often caused the
stepwise increases in the average fluorescence from all wells. For
dilutions of normal uninfected hamster brain (n=32), no increase in
ThT fluorescence was observed in this RT-QuIC assay. Because
there was no gain in sensitivity for 263K-seeded samples and no
increase in fluorescence in NBH control-seeded samples past 45 h
(out to 75 h, not shown), we terminated our 263K experiments at
45 h. Developmental experiments that compared some conditions
of the ASA and RT-QuIC reactions indicated that the retardation
of spontaneous amyloid formation in the latter was largely due to
the lack of guanidine hydrochloride (Fig. S1), the choice of
appropriate NaCl concentrations (see below), and the use of
intermittent, rather than continuous, shaking (data not shown).
The observation that diminishing proportions of the replicate
RT-QuIC reactions were positive at extreme dilutions of the
scrapie BH seed (Fig. 1) was reminiscent of TSE animal bioassays
[27]. In the latter, the Spearman-Ka ¨rber [39] or Reed-Muench
[42] methods are commonly used to estimate infectivity titers in
the original samples [e.g. 50% lethal dose (LD50) per mL] based on
Figure 1. RT-QuIC sensitivity: analysis of dilutions of a scrapie brain homogenate stock. The designated dilutions of 263K scrapie or
normal BH were used to seed RT-QuIC reactions containing recombinant hamster PrP
c 90-231 substrate. Each 0.75 h time point for each dilution is
represented as an average ThT fluorescence from 8 replicate wells on a 96-well plate. The 50% seeding dose (SD50) is defined as the amount giving
sufficiently enhanced ThT fluorescence in half of the replicate wells. In this case, the approximate SD50 was achieved with a 2 ml aliquot (the seed
volume) of a 10
29 dilution of the scrapie BH stock. The Spearman-Ka ¨rber estimate of the SD50/2 ml neat brain tissue is shown, along with that
adjusted to SD50/gram brain tissue.
doi:10.1371/journal.ppat.1001217.g001
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applied the Spearman-Ka ¨rber method to prion seeding activities
by determining the dilution, or seeding dose (SD), giving positive
RT-QuIC responses in 50% of replicate reactions (SD50). The
SD50 concentrations in the undiluted samples were then calculated
to provide a quantitative comparison of relative prion seeding
activities. For example, analysis of the data shown in Figure 1
indicated that the original scrapie brain tissue had 6610
11 SD50
per g (Table 1, Brain #4).
Characterization of RT-QuIC reaction products
To test whether the products of a ThT-positive reaction in the
RT-QuIC assay are similar to those seen previously in our
detergent based QuIC assay, PK-treated RT-QuIC products were
analyzed by Deep Purple non-specific protein staining of SDS-
PAGE gels. 263K scrapie brain-seeded reactions produced a
distinct pattern of PK-resistant bands of ,20, 18, 14 and 13 kDa,
whereas those seeded with normal tissue and those put on ice
without shaking and incubation cycles produced virtually no PK-
resistant polypeptide products (Fig. 2A). The 18-, 14- and 13-kDa
polypeptide bands were similar to those observed in the scrapie-
seeded products of the original QuIC reactions [32] which were
performed using full-length rPrP
c 23-231, rather than rPrP
c 90-
231, as a substrate. The 20-kDa polypeptide band appeared to be
a nearly full length form of the rPrP
c 90-231 substrate, which was
not observed in the original QuIC reactions using the rPrP
c 23-
231 substrate [32]. Quantitative comparison of band intensities of
263K scrapie-seeded RT-QuIC products with and without PK
treatment indicated that the PK-resistant products accounted for
50–60% of the input rPrP
c substrate (data not shown). The 263K
PrP
Sc content of the seed for this reaction was ,10,000-fold lower
than would be detectable by Deep Purple stain and thus was not
visible (data not shown).
We also assessed the conformational changes in the rPrP
C 90-
231 substrate induced by prion seeding in the RT-QuIC by
spectroscopic methods. The circular dichroism (CD) spectrum of
the initial hamster rPrP
C 90-231 substrate showed a minimum at
208 nm and a shoulder at 222 nm (Fig. 2B) that is indicative of
alpha helix content and similar to that reported for native PrP
C
[43]. The Fourier transform infrared (FTIR) absorbance maxi-
mum at 1655 cm
21 (Fig. 2C) was also consistent with high alpha
helix content and similar to previous spectra of rPrP
C in water
[44,45]. In contrast, the product of 263K prion-seeded RT-QuIC
reactions had an FTIR absorbance maximum at 1627 cm
21,
which is indicative of a high beta sheet content similar to that of
brain-derived, PK-treated 263K PrP
res (Fig. 2C) [46]. Thus, the
prion-induced secondary structure changes in rPrP
C 90-231 were




RT-QuIC reproducibility and comparison to bioassay
To assess the reproducibility of the RT-QuIC assay and to
compare its sensitivity to that of infectivity bioassays, we
performed end point dilution analyses of normal and clinical
263K scrapie brain homogenate stocks (four independent stocks of
each), the latter having been titered by end-point dilution bioassay
in hamsters. Ten-fold serial dilutions of each stock were subjected
to three separate RT-QuIC analyses. In the first analysis for each
stock, only 4 replicates per dilution of NBH were used, however 8
replicates were used for all other dilutions and analyses. At least 2
independent batches of buffers and hamster rPrP
c 90-231
substrate were used for the three analyses of each stock. Figure 3
shows the percentage of RT-QuIC-positive wells occurring within
45 h as a function of dilution for each pair of simultaneously
assayed normal and 263K hamster scrapie brain stocks. For each
stock, 100% of the replicate reactions were positive down to 10
27
dilution, but more dilute samples (10
28-10
210) gave lower
percentages of positive replicates. In these experiments, two out
of the 240 negative control wells seeded with normal BH gave
positive responses as shown by the non-zero NBH values in
Figure 3A and C. Whether these apparent false positive reactions
were due to rare spontaneous fibril formation or to inadvertent
prion contamination of the individual wells is unclear. For
comparison, the percentage of replicate animals that were positive
in the hamster bioassays of the three scrapie BH stocks is also
shown (Fig. 3A, B, and C). The data illustrate how, in both the
bioassay and RT-QuIC, the proportion of positive replicates
decreased at similar dilutions of the 263K BH. Table 1
summarizes the results of Spearman-Ka ¨rber calculations of the
SD50 and LD50 per gram brain determined by RT-QuIC and
hamster bioassay, respectively. Although the data in Figure 3
showed similar end-point dilutions for the two types of assays, the
calculated SD50/g values were 0.35–1.5 log higher than the LD50/
g values. These differences can largely be attributed to the fact that
25-fold smaller sample volumes were tested in the RT-QuIC
assays. Overall, the data show that the RT-QuIC and bioassay are
roughly comparable in sensitivity.
The above analyses were performed on brain tissue harvested
from clinically affected hamsters at 80–85 dpi after inoculation
with 50 ml of a 1% 263K scrapie BH. To determine if brain SD50
concentrations increased with time after i.c. scrapie inoculation we
performed end-point dilution RT-QuIC on brains harvested at 10
dpi and calculated a mean SD50 concentration of 10
8.2/g brain
(Fig. 4). The ,4 log10 increase in SD50/g between 10 dpi and the
clinical phase (Fig. 4 and 1) was comparable to the estimated 3-4
log10 increase in infectivity (LD50/g) that was reported in a similar
timeframe in hamsters inoculated with slightly higher i.c. doses
of 263K BH [48]. Thus brain RT-QuIC SD50 concentrations
Table 1. RT-QuIC and animal bioassay end point dilution analyses.




rd Rxn Avg ± Std Dev log LD50 per g Brain*
Brain #1 12.1 12.0 11.6 11.960.26 10.2
Brain #2 11.2 11.3 11.6 11.460.19 9.80
Brain #3 11.2 11.5 11.8 11.560.31 10.7
Brain #4 11.3 12.2 11.8 11.860.44 10.4
*calculated by Spearman-Ka ¨rber analysis as described in Materials and Methods.
doi:10.1371/journal.ppat.1001217.t001
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PLoS Pathogens | www.plospathogens.org 5 December 2010 | Volume 6 | Issue 12 | e1001217Figure 2. SDS-PAGE, circular dichroism (CD), and Fourier transform infrared spectroscopy analyses of RT-QuIC products. RT-QuIC
reactions were seeded with 5610
26 dilution of either NBH or 263K BH (containing 100 fg PrP
Sc). (A) Products were PK digested and analyzed by SDS-
PAGE. The gel was stained with a non-specific protein stain (Deep Purple). The circle indicates the ,18 and 19 kDa bands while the bracket
represents the ,13 and 14 kDa bands in the PK-digested products of the scrapie-seeded reaction. (B) CD spectrum of the initial hamster rPrP
C 90-231
substrate for RT-QuIC reactions. (C) FTIR spectra of hamster rPrP
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inoculation.
RT-QuIC analyses of nasal lavages
Recently prions have been detected in nasal lavages from
hamsters clinically affected with the Hyper (HY) strain of hamster-
adapted transmissible mink encephalopathy (TME) by hamster
inoculation and the original immunoblot-based QuIC reaction
[24]. To quantitate the amount of prion seeding activity in lavages
and to evaluate the RT-QuIC assay with another prion strain and
tissue source, we analyzed coded samples of nasal lavages from
HY-TME-infected and normal hamsters, as well as lavage buffers
spiked with dilutions of HY-TME BH. As shown in Figure 5A,
2 mL aliquots of lavage buffer spiked with a 10
27 dilution of HY-
TME brain tissue were positive in all replicate RT-QuIC reactions
whereas further 10-fold dilutions were negative. All unspiked neat
nasal lavage samples from HY-TME-infected animals were
positive and by comparison, all negative control nasal lavages
from normal hamsters, and all lavage buffer samples spiked with
normal BH were negative in replicate reactions (Fig. 5). These
results showed that prions were readily detected in nasal lavages
from HY-affected hamsters by RT-QuIC.
We then performed end point dilution analyses of eight nasal
lavage samples from HY-TME infected hamsters. Data from three
representative nasal lavage analyses is shown in Figure 5B. The
calculated SD50 concentrations for all the lavages are shown in
Table 2 and compared to incubation times and attack rates from
intracerebral inoculations of neat 50 mL aliquots of those lavages
into hamsters. The hamster inoculations indicated the presence of
prion infectivity in the lavages. However, the extended and
variable incubation periods make it difficult to estimate relative
infectivity levels in most of these samples based on the hamster
inoculations without bioassay end point dilution analyses.
Quantification by the RT-QuIC gave SD50 concentrations that
were as high as 10
5.7 per mL lavage. Considering the major
dilution effect of rinsing the nasal cavity of hamsters with 1 mL of
buffer, these results indicate that substantial concentrations of
infectivity can be present in endogenous nasal fluids of HY TME-
infected hamsters.
Prion seeding activity in CSF
In order to quantitate the prion seeding activity in CSF, we
performed endpoint dilution analysis on CSF samples from two
hamsters that were clinically affected with 263K scrapie. Values of
Figure 3. Combined RT-QuIC end-point dilution analyses from four scrapie BH stocks. Each 263K stock (Brain #1-#4 corresponding to
Panels A-D) was serially diluted and used to seed RT-QuIC reactions. The percentage of replicate wells (n=4–8) that are ThT-positive according to the
criteria in Material and Methods was calculated and the mean percentage 6 standard deviation from three separate experiments with each stock is
shown. Animal bioassay data is represented as the percentage of replicate animals reaching the clinical stage of disease at each dilution of 263K
scrapie BH (4–22 animals per dilution per stock).
doi:10.1371/journal.ppat.1001217.g003
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5.6 and 10
4.7 SD50 per mL were obtained (Fig. 6). One of the
CSF samples (Fig. 6B) was tinted slightly red, presumably from
contamination by blood, whereas the other CSF sample (Fig. 6A)
was clear. In the former case, the RT-QuIC reactions seeded by
the neat CSF were inhibited relative to those seeded with the
10
20.7 and 10
21.4 dilutions. We suspect that, consistent with our
failed attempts to detect prions directly in blood or scrapie-spiked
blood (data not shown), blood contaminants in the neat red-tinted
CSF sample inhibited the RT-QuIC reactions, but were rapidly
diluted to subinhibitory levels.
RT-QuIC tolerances for tissue components
To explicitly test for interference of the RT-QuIC by
components of CSF and other tissues, we spiked neat CSF or
10% homogenates of spleen and muscle from normal hamsters, or
serial 5-fold dilutions thereof, with a 10
26.3 dilution (100 fg PrP
Sc)
of hamster 263K scrapie BH or normal BH. We observed partial-
to-complete inhibition of the RT-QuIC reactions seeded with 2 ml
seed aliquots containing 2–10% (10
21.7-10
21.0) muscle tissue and
0.4–10% (10
22.4-10
21.0) spleen tissue, but no inhibition by clear
CSF (Fig. 7). However, further dilutions of the muscle and spleen
tissue relieved the inhibition. In other experiments, we also have
observed inhibition by $1% hamster brain tissue and 100%
human plasma (data not shown). Thus, concentrated tissue
components from various tissues (e.g. muscle, spleen, brain
and blood) can interfere with the RT-QuIC reaction, making
it important to reduce those components to subinhibitory
concentrations.
Adaptation of RT-QuIC to other species
To test the applicability of the RT-QuIC assay to other prion
disease susceptible species, we seeded RT-QuIC reactions with
BH’s from chronic wasting disease (CWD)-infected deer and
scrapie-infected sheep, as well as negative control animals. In these
reactions, full-length cervid (PrP genotype G96M132S138S225Q226),
sheep (PrP genotype V136R154Q171), and hamster rPrP
c substrates
homologous with the PrP
Sc molecules in the seed materials were
used, except in the case of the reactions seeded with uninfected
negative control sheep brain homogenate. In this case, we lacked
the matching negative control brain material (i.e., VRQ) and had
to substitute brain homogenate from a slightly different scrapie-
susceptible sheep genotype (A136R154Q171). When reaction
conditions like those of the hamster scrapie-compatible reaction
described above were used with concentrated seeds, e.g. 10
24
dilutions of infected brain tissue, all replicate reactions were
positive within 30 h and 40 h for the CWD and sheep scrapie
seeds, respectively (data not shown). To further optimize these
assays for detecting low levels of prions, we varied the NaCl
concentrations in reactions seeded with highly diluted seed
samples (10
26-10
27; 4-10 fg PrP
Sc equivalents). Good discrimina-
tion between prion-seeded and negative control reactions was
found with 300–400 mM NaCl for the sheep reactions (Fig. 8A)
and 200–300 mM NaCl for the deer reactions (Fig. 8B). The latter
conditions were also optimal for 263K scrapie-seeded RT-QuIC
reactions using full-length hamster rPrP
c substrate (Fig. 8C). At
these respective NaCl concentrations, negative control reactions
from all species were negative (n=76) for 68 h. Higher NaCl
concentrations tended to reduce the prion-seeded positive
reactions and/or enhance the likelihood of apparently spontane-
ous positive responses in negative control reactions. In summary,
these results show that the RT-QuIC can be applied to the
detection of prions from deer and sheep brain infected with CWD
and scrapie, respectively.
Discussion
The RT-QuIC is a rapid prion detection assay that is more
amenable to high-throughput applications than the original QuIC
Figure 4. RT-QuIC end-point dilution analysis of three 263K-inoculated preclinical 10 dpi hamster BHs. Hamsters were i.c.-inoculated
with 263K scrapie BH. Animals were sacrificed at 10 dpi and brains were analyzed with RT-QuIC dilution analysis. Eight replicate wells were used for
each BH dilution. The average Spearman-Ka ¨rber estimates of the SD50/2 ml and SD50/g neat brain tissue from three animals are shown.
doi:10.1371/journal.ppat.1001217.g004
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reactions than the ASA assay. The sensitivity of the RT-QuIC is
similar to the in vivo bioassay in hamsters, but is roughly 50–200
times faster and much less expensive.
Using this assay, we have been able to rapidly detect and
quantify prion seeding activities in nasal lavages from clinically
TME-affected hamsters. Considering that nasal lavages are likely
to dilute endogenous nasal cavity fluids by at least 100-fold, these
results confirm and extend a previous report of substantial prion
infectivity in nasal secretions from hamsters in the clinical phase of
HY TME infection [24]. In the previous report, we detected nasal
fluid prions by bioassay and the original immunoblot-based QuIC
Figure 5. RT-QuIC detection and end point dilution analysis of nasal lavages from HY-TME-infected hamsters. At the clinical stage of
disease in hamsters i.c.-inoculated with HY-TME, nasal lavage samples (,1 ml) were collected from individual hamsters, serially diluted and used to
seed RT-QuIC reactions. (A) Detection of HY-TME in nasal lavages is shown. As positive and negative controls, 5610
-6-fold dilutions of hamster scrapie
BH (containing ,100 fg PrP
Sc) and NBH, respectively, were used as seeds. Dilutions of HY-TME brain were also tested for comparison. The data points
show the average ThT fluorescence of 8 replicate wells. (B) Three representative HY-TME infected hamster lavages were serially diluted and analyzed
by RT-QuIC. Each data point represents the percentage of replicate wells (n=4) that are ThT-positive according to the criteria in Material and Methods
as a function of nasal lavage dilution factor. The tabular data from lavages tested here can be found in Table 2.
doi:10.1371/journal.ppat.1001217.g005
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quantitate prion seeding activity in nasal lavages using the RT-
QuIC raises the possibility that such testing of nasal lavages or
swabs could help in diagnosing prion disease infections of humans
and animals on a high-throughput basis.
Our detection and quantitation of prion seeding activity in the
CSF of 263K scrapie-infected hamsters suggests that CSF, being a
relatively accessible specimen, should be collected for prion disease
diagnosis by RT-QuIC. Interestingly, the CSF SD50 levels (10
5.7
and 10
4.6/ml) (Fig. 8) were similar to the highest value obtained for
nasal lavages (10
5.7/ml) (Table 2). However, the CSF should have
at least 100-fold lower levels of prion seeding activity than the
endogenous nasal fluids, given the considerable dilution that
occurs when the nasal cavities are flushed with lavage buffer.
The origin of the rare positives that we observed in negative
control RT-QuIC reactions (Fig. 3) is difficult to ascertain.
Because we simultaneously tested both positive and negative
controls on the same plates, there was some, but obviously very
low, potential for prion seeds to be inadvertently transferred from
prion-seeded wells to adjacent negative control reactions. More-
over, given the very high sensitivity of the assay, even a minute
contamination could elicit a false-positive reaction. Yet another
explanation could be a cross contamination due to a failure of our
plate sealer tape during the course of the reaction incubation.
Fortunately, whether due to contamination or spontaneous
amyloidogenesis, such apparent false positives are extremely rare
and can simply be retested for confirmation.
It is likely that the same multimeric particles of abnormal PrP
that stimulate conversion of PrP
C or rPrP
c to an abnormally folded
form in in vitro reactions also cause prion ‘‘infections’’ in vivo.
Consistent with this idea, we found that positive RT-QuIC
reactions were obtained only with seeds derived from TSE-
infected animals (except for the rare exceptions described above).
Moreover, we obtained similar end-point dilutions of scrapie BH
with both the bioassay and the RT-QuIC (Fig. 3). These results
gave the appearance of a direct quantitative correspondence
between the activities measured in these assays. Indeed, we expect
that for prions of a particular strain and tissue source, there will be
a proportional relationship between the activities measured by
end-point dilution analyses with the RT-QuIC and animal
bioassay. However, the sensitivities of these distinct assays will
likely be influenced by some fundamentally different factors in vitro
and in vivo and should not be expected to coincide as closely as they
have in Figure 3 with all types of prion samples or all permutations
of the assays. Indeed, further studies will be required to determine
whether RT-QuIC assays detect naturally occurring PrP aggre-
gates that are associated with familial PrP mutations and disease,
but are non-infectious in bioassays. This anticipated variability of
the RT-QuIC and bioassay with different prion sample types does
not diminish the utility of the RT-QuIC in assessing the relative
amount of prion seeding activity in samples of similar nature. In
further developments of RT-QuIC assays for certain purposes, e.g.
diagnostic testing, the possibility that certain abnormal non-PrP
amyloids could give false positive RT-QuIC reactions should also
be considered.
The end-point dilution strategy for determining relative seed
concentrations should be applicable to amyloid seeding assays for
a variety of misfolded protein aggregates regardless of the means of
detecting the amyloid product, e.g. by ThT fluorescence as in the
ASA [34] and RT-QuIC assays, or immunoblotting as in PMCA
[8], rPrP-PMCA [31] or original QuIC [32] assays. Like the RT-
QuIC, many amyloid-seeded polymerization reactions progress
rapidly to completion after a lag phase, providing an all-or-nothing
response within appropriately selected time frames. This typical
feature of seeded polymerization reactions should facilitate
determinations of the proportion of positive reactions among
replicates at a given sample dilution. Analyses of data from serial
dilutions of various samples using the Spearman-Ka ¨rber [39] or
Reed-Muench [42] algorithms can improve estimates of SD50
values per unit volume, which then indicate the relative
concentrations of seeding activity in the samples.
As noted above, Chen and colleagues have recently described
an alternative means of obtaining quantitative estimates of prion
seeding activity using PMCA reactions, called qPMCA [36].
Rather than assaying serial dilutions of a sample and determining
the end point dilution, as we demonstrate here, a single sample
dilution is assayed in serial PMCA reactions and the relative
seeding activity is estimated from the number of serial PMCA
rounds that are required to detect a positive response. The
accuracy of qPMCA therefore depends on the strength of the
inverse correlation between the prion seed concentration and
number of rounds required. Although these investigators have
documented such a correlation, its biochemical/kinetic basis
remains unclear. In contrast, end-point dilution analyses can
simply be explained as a titration of the active species to the
detection limit. Further studies will be required to determine
which approach to estimating relative prion concentrations is
more robust and practical for comparing specific sample types.
Within individual RT-QuIC experiments composed of multiple,
simultaneous reactions, we observed a clear dependence of the lag
Table 2. HY-TME nasal lavage analyses: comparison of RT-QuIC SD50 with incubation period in hamsters.
Nasal Lavage (Animal number) RT-QuIC Inoculations
log SD50/mL* Avg Incubation Time (d) ± Std Dev Clinical/Inoculated
#1 4.7 114613.1 6/6
#2 4.7 11869.50 6/6
#3 5.2 121613.8 6/6
#4 5.7 125611.3 6/6
#5 4.2 151648.1 5/6
#6 4.2 185644.0 6/6
#7 4.2 186627.5 5/6
#8 3.5 192637.0 3/6
*calculated by Spearman-Ka ¨rber analysis as described in Materials and Methods.
doi:10.1371/journal.ppat.1001217.t002
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lag phase might be considered analogous to the TSE incubation
period between the inoculation and the near terminal stage of
disease. In certain combinations of host and TSE strain, standard
curves correlating bioassay incubation period with inoculated dose
can be established and used to determine relative prion infectivity
levels in unknown samples without resorting to more time-
consuming and animal-intensive end-point dilution analyses. An
analogous correlation between prion seed concentration and lag
phase in the seeding assays like the RT-QuIC or ASA might also
Figure 6. RT-QuIC end-point dilution analysis of CSF from scrapie-infected hamsters. CSF was collected at the clinical stage of disease
from two individual hamsters (Panel A and B) i.c.-inoculated with 263K scrapie BH. CSF was serially diluted 5-fold and analyzed by RT-QuIC. Each
0.75 h time point for each dilution is represented as an average ThT fluorescence from 8 replicate wells. The average Spearman-Ka ¨rber estimates of
the SD50/2 ml (the seed volume) and SD50/ml neat CSF are shown.
doi:10.1371/journal.ppat.1001217.g006
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PLoS Pathogens | www.plospathogens.org 11 December 2010 | Volume 6 | Issue 12 | e1001217Figure 7. Tissue tolerance of RT-QuIC assay. RT-QuIC reactions with recombinant hamster 90-231 PrP
c substrate were seeded with 2 mL neat or
diluted samples of cerebral spinal fluid (A), 10% muscle (B), or 10% spleen (C), each spiked with a 10
26.3 dilution of normal or 263K scrapie-infected
(clinical) hamster BH. Each 0.75 h time point for each dilution is represented as an average ThT fluorescence from 4 replicate wells.
doi:10.1371/journal.ppat.1001217.g007
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of each unknown. However, further work will be required to
determine the efficacy, reproducibility, and validity of such an
approach. In the mean time, the end-point dilution approach
described in the current manuscript provides a clear means of
quantitating prion seeding activity.
In summary, the end-point dilution RT-QuIC analysis provides
quantitative comparisons of prion seeding activity. Although the
extent to which prion seeding activity correlates quantitatively
with infectivity in vivo under various other circumstances remains
to be determined, we have shown that the RT-QuIC assay
provides rapid and highly sensitive discrimination of prion-infected
and uninfected brain tissues, nasal lavages, and CSF.
Supporting Information
Figure S1 Guanidine HCl effects in RT-QuIC reactions seeded
with sheep scrapie and deer CWD. Dilutions of sheep scrapie
(10
-3.9; ,100 fg PrP
Sc) (A) and deer CWD (10
-5.3; ,40 fg PrP
CWD)
(B) BH’s and corresponding dilutions of NBH from the same
species were used to seed RT-QuIC reactions. The guanidine-HCl
concentration in the reactions was varied as designated. All
reactions utilized the homologous full length rPrP
C substrates. The
data points show the average ThT fluorescence of 4 and 8
replicate wells respectively.
Found at: doi:10.1371/journal.ppat.1001217.s001 (0.24 MB TIF)
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